ViewPoint Therapeutics Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
ViewPoint Therapeutics General Information
Description
Developer of crystallin stabilizers designed to prevent and treat cataracts and presbyopia. The company's crystallin stabilizers include a small molecule that is active in preclinical models of age-related cataracts via a target-based screening and optimization effort, enabling physicians to have drugs that prevent or reverse protein misfolding, which is implicated in numerous common disorders of aging including cataracts, presbyopia, and neurodegenerative diseases.
Contact Information
Website
www.viewpointtherapeutics.comCorporate Office
- 2388 48th Avenue
- San Francisco, CA 94116
- United States
Corporate Office
- 2388 48th Avenue
- San Francisco, CA 94116
- United States
ViewPoint Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 28-Jul-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 08-Nov-2019 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 05-Mar-2018 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 02-May-2016 | Completed | Generating Revenue | |||
| 3. Grant | 01-Apr-2016 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | 06-Oct-2014 | Completed | Generating Revenue |
ViewPoint Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
ViewPoint Therapeutics Comparisons
Industry
Financing
Details
ViewPoint Therapeutics Competitors (36)
One of ViewPoint Therapeutics’s 36 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Muna Therapeutics | Venture Capital-Backed | Frederiksberg, Denmark | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| WaveBreak | Venture Capital-Backed | Boston, MA | ||||
| CervoMed | Formerly VC-backed | Boston, MA |
ViewPoint Therapeutics Patents
ViewPoint Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022047315-A1 | Compounds and formulations for treating ophthalmic diseases | Inactive | 31-Aug-2020 | ||
| EP-3716981-A1 | Compounds for treating near vision disorders | Inactive | 28-Nov-2017 | ||
| US-20200276211-A1 | Compounds for treating near vision disorders | Inactive | 28-Nov-2017 | ||
| WO-2019108673-A1 | Compounds for treating near vision disorders | Inactive | 28-Nov-2017 | ||
| AU-2016321254-A1 | Compounds and formulations for treating ophthalmic diseases | Inactive | 08-Sep-2015 | A61K31/575 |
ViewPoint Therapeutics Signals
ViewPoint Therapeutics Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Asset Management Ventures | Venture Capital | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Codon Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Innovation Partnerships | Venture Capital | Minority |
ViewPoint Therapeutics FAQs
-
When was ViewPoint Therapeutics founded?
ViewPoint Therapeutics was founded in 2014.
-
Where is ViewPoint Therapeutics headquartered?
ViewPoint Therapeutics is headquartered in San Francisco, CA.
-
What is the size of ViewPoint Therapeutics?
ViewPoint Therapeutics has 11 total employees.
-
What industry is ViewPoint Therapeutics in?
ViewPoint Therapeutics’s primary industry is Drug Discovery.
-
Is ViewPoint Therapeutics a private or public company?
ViewPoint Therapeutics is a Private company.
-
What is ViewPoint Therapeutics’s current revenue?
The current revenue for ViewPoint Therapeutics is .
-
How much funding has ViewPoint Therapeutics raised over time?
ViewPoint Therapeutics has raised $39M.
-
Who are ViewPoint Therapeutics’s investors?
Asset Management Ventures, BVF Partners, Codon Capital, , and Innovation Partnerships are 5 of 16 investors who have invested in ViewPoint Therapeutics.
-
Who are ViewPoint Therapeutics’s competitors?
Voyager Therapeutics, Muna Therapeutics, Alzheon, WaveBreak, and CervoMed are some of the 36 competitors of ViewPoint Therapeutics.
-
When was ViewPoint Therapeutics acquired?
ViewPoint Therapeutics was acquired on 28-Jul-2022.
-
Who acquired ViewPoint Therapeutics?
ViewPoint Therapeutics was acquired by Visus Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process